Graphite Bio (GRPH) Short Interest Ratio & Short Volume → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free GRPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Graphite Bio Short Interest DataCurrent Short Volume704,000 sharesPrevious Short Volume740,800 sharesChange Vs. Previous Month-4.97%Dollar Volume Sold Short$2.39 millionShort Interest Ratio / Days to Cover3.0Last Record DateFebruary 29, 2024Outstanding Shares58,240,000 sharesFloat Size27,480,000 sharesShort Percent of Float2.56%Today's Trading Volume328,300 sharesAverage Trading Volume282,405 sharesToday's Volume Vs. Average116% Short Selling Graphite Bio ? Sign up to receive the latest short interest report for Graphite Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGRPH Short Interest Over TimeGRPH Days to Cover Over TimeGRPH Percentage of Float Shorted Over Time Ad Manward PressAmazon's betting big on this unknown AI companyAmazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company Graphite Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/2024704,000 shares $2.39 million -5.0%2.6%3 $3.39 2/15/2024740,800 shares $2.24 million -7.6%2.7%4.7 $3.02 1/31/2024801,800 shares $2.18 million -31.5%2.9%4.5 $2.72 1/15/20241,170,000 shares $3.21 million -4.9%4.3%6.5 $2.74 12/31/20231,230,000 shares $3.22 million -2.4%4.5%7.3 $2.62 12/15/20231,260,000 shares $2.84 million -6.0%4.6%7.7 $2.25 Get the Latest News and Ratings for GRPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter. 11/30/20231,340,000 shares $3.04 million +8.9%4.9%9.8 $2.27 11/15/20231,230,000 shares $2.77 million No Change4.5%10.2 $2.25 10/31/20231,230,000 shares $3.06 million -1.6%4.5%10.8 $2.49 10/15/20231,250,000 shares $2.99 million -2.3%4.6%11.2 $2.39 9/30/20231,280,000 shares $3.17 million +6.7%4.7%11 $2.48 9/15/20231,200,000 shares $2.76 million +13.2%4.4%10.5 $2.30 8/31/20231,060,000 shares $2.35 million +7.0%3.9%7 $2.22 8/15/2023990,500 shares $2.43 million -13.1%3.6%6.6 $2.45 7/31/20231,140,000 shares $2.88 million -0.9%4.2%8.1 $2.53 7/15/20231,150,000 shares $3.02 million +4.6%4.2%7.5 $2.63 6/30/20231,100,000 shares $2.86 million +56.6%4.0%6.4 $2.60 6/15/2023702,400 shares $2.04 million +4.5%2.6%4.2 $2.91 5/31/2023672,500 shares $1.91 million -11.8%2.4%5.3 $2.84 5/15/2023762,400 shares $2.42 million No Change2.8%3.8 $3.17 10/31/20221,250,000 shares $4.39 million -3.9%4.7%6.8 $3.51 10/15/20221,300,000 shares $3.98 million -1.5%4.9%6.7 $3.06 9/30/20221,320,000 shares $4.18 million -6.4%5.0%5.7 $3.17 9/15/20221,410,000 shares $5.17 million -8.4%5.3%3.9 $3.67 8/31/20221,540,000 shares $5.10 million +1.3%5.8%3.6 $3.31 8/15/20221,520,000 shares $6.44 million -11.6%5.8%3.1 $4.24 7/31/20221,720,000 shares $5.42 million -26.8%7.2%2.7 $3.15 7/15/20222,350,000 shares $7.78 million -4.9%9.8%3.4 $3.31 6/30/20222,470,000 shares $6.79 million -20.1%10.3%3.5 $2.75 6/15/20223,090,000 shares $7.20 million +19.8%12.9%4.7 $2.33 5/31/20222,580,000 shares $6.06 million -2.3%10.8%4.3 $2.35 5/15/20222,640,000 shares $6.86 million +7.8%11.0%4.9 $2.60 4/30/20222,450,000 shares $9.85 million -5.0%10.2%6.3 $4.02 4/15/20222,580,000 shares $11.07 million -36.0%10.7%8 $4.29 3/31/20224,030,000 shares $20.55 million +33.0%N/A13.6 $5.10 3/15/20223,030,000 shares $23.82 million +5.6%12.4%10.9 $7.86 2/28/20222,870,000 shares $26.40 million +3.6%11.7%12.7 $9.20 2/15/20222,770,000 shares $30.28 million +1.5%11.3%11.4 $10.93 1/31/20222,730,000 shares $25.50 million -6.8%11.1%11.2 $9.34 1/15/20222,930,000 shares $29.48 million +7.3%N/A12.1 $10.06"The Biggest Drug Ever" Is Coming (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> GRPH Short Interest - Frequently Asked Questions What is Graphite Bio's current short interest? Short interest is the volume of Graphite Bio shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 704,000 shares of GRPH short. 2.56% of Graphite Bio's shares are currently sold short. Learn More on Graphite Bio's current short interest. What is a good short interest ratio for Graphite Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRPH shares currently have a short interest ratio of 3.0. Learn More on Graphite Bio's short interest ratio. What is a good short interest percentage for Graphite Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.56% of Graphite Bio's floating shares are currently sold short. Is Graphite Bio's short interest increasing or decreasing? Graphite Bio saw a decrease in short interest in February. As of February 29th, there was short interest totaling 704,000 shares, a decrease of 5.0% from the previous total of 740,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Graphite Bio's float size? Graphite Bio currently has issued a total of 58,240,000 shares. Some of Graphite Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Graphite Bio currently has a public float of 27,480,000 shares. How does Graphite Bio's short interest compare to its competitors? 2.56% of Graphite Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Graphite Bio: Adverum Biotechnologies, Inc. (8.04%), Genfit S.A. (0.18%), Compugen Ltd. (2.25%), Elevation Oncology, Inc. (11.46%), Fennec Pharmaceuticals Inc (7.82%), Cellectis S.A. (1.18%), Kodiak Sciences Inc. (3.76%), Century Therapeutics, Inc. (5.00%), X4 Pharmaceuticals, Inc. (7.85%), INmune Bio, Inc. (13.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Graphite Bio stock? Short selling GRPH is an investing strategy that aims to generate trading profit from Graphite Bio as its price is falling. GRPH shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Graphite Bio? A short squeeze for Graphite Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRPH, which in turn drives the price of the stock up even further. How often is Graphite Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRPH, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Adverum Biotechnologies Short Interest Data Genfit Short Interest Data Compugen Short Interest Data Elevation Oncology Short Interest Data Fennec Pharmaceuticals Short Interest Data Cellectis Short Interest Data Kodiak Sciences Short Interest Data Century Therapeutics Short Interest Data X4 Pharmaceuticals Short Interest Data INmune Bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRPH) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeProtect Your Bank Account Before It’s Too LateWeiss Ratings